Meta's new hyperagent framework breaks the AI "maintenance wall," allowing systems to autonomously rewrite their own logic ...

The study titled “The Attention Mismatch: Mapping the Structural Academic Governance Deficit in the Age of Generative AI” is a large-scale, multi-layered analysis of how AI-generated content is ...

We have reached the 2026 NBA playoffs and it’s time to start handicapping Round 1 series angles. Hopefully, most of you are ...

There are always too many standards to meet and assignments to grade. These strategies can help you reject haste in favor of ...

Unspendable Labs today announced that Kontor, its next-generation Bitcoin metaprotocol, has launched a file storage system on Bitcoin’s signet test network. The system allows anyone to store files ...

Viv Govender of Rand Swiss discusses how investment decisions in AI infrastructure are shaping competitive positioning across ...

SPDR S&P Biotech ETF (XBI) holds 150+ equal-weight positions and is up 46% over the past year, but faces near-term headwinds from FDA staffing cuts that could slow the regulatory approval pipeline ...

A few AI labs have pulled away from the pack over the last few years, and they might be able to maintain this advantage going forward. Google DeepMind CEO Demis Hassabis believes that the leading ...

Unpriced disaster risk lurks beneath market surfaces, urging investors to consider hazard rates in valuations and resilience ...

Meta AI launches Archimedes, its first superintelligence model from $10B research team. Performance specs, access details & industry impact analysis.

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...